Mebendazole as Adjuvant Treatment for Colon Cancer

Recruiting now · Phase 3

Conditions studied: Colorectal Cancer

In brief

mebendazole treating colon cancer

Key facts

Study ID

NCT03925662

Run by

Sherief Abd-Elsalam

People needed

40

Starts

2019-04-01

Expected to finish

2028-12-01

Last updated by the study team

2019-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Colorectal cancer stage 4.

You may not qualify if…

• Agranulocytosis
• Pregnancy
• Allergy to mebendazole.

Where it is running

• Sherief Abd-Elsalam — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.